Osterweis Capital Management Inc. Buys New Shares in Transcat, Inc. $TRNS

Osterweis Capital Management Inc. purchased a new stake in Transcat, Inc. (NASDAQ:TRNS) during the 2nd quarter, Holdings Channel reports. The firm purchased 132,797 shares of the scientific and technical instruments company’s stock, valued at approximately $12,320,000.

Other large investors also recently modified their holdings of the company. Deutsche Bank AG boosted its stake in shares of Transcat by 4.6% during the 4th quarter. Deutsche Bank AG now owns 7,053 shares of the scientific and technical instruments company’s stock worth $400,000 after buying an additional 312 shares during the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. increased its position in shares of Transcat by 6.3% in the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 5,462 shares of the scientific and technical instruments company’s stock valued at $407,000 after acquiring an additional 325 shares during the last quarter. Swiss National Bank raised its holdings in Transcat by 2.2% during the fourth quarter. Swiss National Bank now owns 18,315 shares of the scientific and technical instruments company’s stock worth $1,039,000 after acquiring an additional 400 shares in the last quarter. Price T Rowe Associates Inc. MD boosted its position in Transcat by 8.9% during the fourth quarter. Price T Rowe Associates Inc. MD now owns 5,265 shares of the scientific and technical instruments company’s stock valued at $299,000 after purchasing an additional 432 shares during the last quarter. Finally, Diversified Trust Co boosted its position in Transcat by 8.8% during the first quarter. Diversified Trust Co now owns 5,495 shares of the scientific and technical instruments company’s stock valued at $404,000 after purchasing an additional 444 shares during the last quarter. 98.34% of the stock is currently owned by institutional investors and hedge funds.

Insider Buying and Selling

In related news, Director Craig D. Cairns acquired 1,050 shares of the stock in a transaction on Thursday, August 6th. The shares were purchased at an average price of $93.97 per share, for a total transaction of $98,668.50. Following the purchase, the director directly owned 1,480 shares in the company, valued at approximately $139,075.60. The trade was a 244.19% increase in their ownership of the stock. The purchase was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, Director Christopher P. Gillette sold 504 shares of the business’s stock in a transaction dated Friday, August 7th. The shares were sold at an average price of $94.23, for a total value of $47,491.92. Following the completion of the transaction, the director directly owned 200 shares of the company’s stock, valued at approximately $18,846. This trade represents a 71.59% decrease in their position. The SEC filing for this sale provides additional information. 1.80% of the stock is currently owned by company insiders.

Transcat Stock Performance

TRNS opened at $87.38 on Tuesday. The company has a quick ratio of 2.11, a current ratio of 2.49 and a debt-to-equity ratio of 0.36. Transcat, Inc. has a 12-month low of $50.23 and a 12-month high of $100.00. The business has a 50 day moving average of $90.18 and a 200-day moving average of $82.13. The stock has a market cap of $817.88 million, a price-to-earnings ratio of 236.16 and a beta of 0.68.

Transcat (NASDAQ:TRNS) last released its quarterly earnings data on Tuesday, August 4th. The scientific and technical instruments company reported $0.51 EPS for the quarter, topping analysts’ consensus estimates of $0.38 by $0.13. The firm had revenue of $92.95 million during the quarter, compared to analysts’ expectations of $86.55 million. Transcat had a net margin of 0.99% and a return on equity of 5.56%. On average, equities research analysts expect that Transcat, Inc. will post 1.74 earnings per share for the current year.

Analyst Ratings Changes

TRNS has been the topic of several recent analyst reports. Weiss Ratings raised Transcat from a “sell (d)” rating to a “sell (d+)” rating in a research report on Thursday, May 28th. Northland Securities downgraded Transcat from an “outperform” rating to a “market perform” rating and set a $95.00 price objective for the company. in a report on Wednesday, August 5th. Wall Street Zen raised shares of Transcat from a “sell” rating to a “hold” rating in a research note on Sunday, June 28th. Finally, Zacks Research upgraded shares of Transcat from a “strong sell” rating to a “hold” rating in a report on Friday, May 15th. Two research analysts have rated the stock with a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat, Transcat currently has an average rating of “Reduce” and an average target price of $95.00.

About Transcat

Transcat, Inc (NASDAQ: TRNS) is a leading provider of calibration, laboratory, and metrology services in North America. Founded in 1964 and headquartered in Ronkonkoma, New York, the company specializes in ensuring the accuracy and compliance of measurement instruments across a wide range of industries. Transcat operates a network of ISO/IEC 17025–accredited laboratories and offers on-site field calibration, instrument repair, and preventive maintenance services.

In addition to its calibration services, Transcat distributes precision instrumentation and related software solutions from top manufacturers.